MyFinsight
Home
Blog
About
Proceeds from maturities
of marketable...
$24,218K
(-80.68%↓ Y/Y)
Proceeds from (payments
for) equity...
$4,631K
(268.95%↑ Y/Y)
Net cash provided by
(used in) investing...
$19,911K
(-57.97%↓ Y/Y)
Net cash provided by
(used in) financing...
$4,631K
(268.95%↑ Y/Y)
Canceled cashflow
$4,307K
Net increase
(decrease) in cash, cash...
-$32,755K
(-45.94%↓ Y/Y)
Canceled cashflow
$24,542K
Stock-based compensation
expense
$23,832K
(-25.76%↓ Y/Y)
Net income (loss)
$17,956K
(119.46%↑ Y/Y)
Loss (income) from
equity method...
-$7,596K
(-142.00%↓ Y/Y)
Depreciation and
amortization
$6,864K
(-51.64%↓ Y/Y)
Other, net
-$446K
(-114.35%↓ Y/Y)
Purchases of property,
equipment, and capitalized...
$3,447K
(-51.44%↓ Y/Y)
Purchase of intangible
assets
$860K
(-91.15%↓ Y/Y)
Net cash provided by
(used in) operating...
-$57,297K
(14.57%↑ Y/Y)
Canceled cashflow
$56,694K
Changes in operating
assets and liabilities
$113,991K
(909.54%↑ Y/Y)
Back
Back
Cash Flow
agilon health, inc. (AGL)
agilon health, inc. (AGL)
source: myfinsight.com